Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use-result survey of Daichirona intramuscular injection
jRCT2031240151Recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2024
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Safety Specifications of Daichirona. Started Sep 2024; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031240151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240151.